Alexandra Hunt
Alexandra M. Hunt is an American political candidate, public health worker, published research scientist, and activist from Pennsylvania. She is a member of the Democratic Party. Hunt has run to represent in the United States [House of Representatives] and to serve as city controller of Philadelphia.
Early life and career
Hunt is from Rochester, New York. She had attended the private school Allendale Columbia school in the suburbs, where both of her parents worked as teachers. She has a twin brother. Her twin brother struggled with a learning disability. She moved out of her mother's house while still in high school. Hunt attended the University of Richmond; she worked her way through college by working as a server and a stripper. She completed her Bachelor of Science in psychology in 2014.After graduating from Richmond, Hunt moved to Philadelphia, where she earned a Master of Science in interdisciplinary health sciences at Drexel University and a Master of Public Health from Temple University. During Hunt's time at Drexel University, she contributed to a group project in college researching HSV-1 activating the DNA damage response, and assisted on a group college research project with her classmates on oxygen exposure during cardiopulmonary resuscitation in a preclinical trial at Children's Hospital of Philadelphia. Hunt said she rode as an emergency medical technician with Plymouth Meeting Ambulance Association. Alexandra also said she worked at Fox Chase Cancer Center in the clinical research department when the COVID-19 pandemic began and volunteered in the community at COVID-19 testing sites and distributing food and other necessities. During Hunt's time in clinical research, she said she published group college project research articles on psychological distress in patients with metastatic cancer, the use of the NCCN thermometer to measure the prevalence and correlates of psychological distress in cancer patients, and the feasibility of using food frequency questionnaire to assess dietary patterns in patients with advanced gastrointestinal malignancies.